Trevi Therapeutics Inc Share Price Today: Live Updates & Key Insights
Trevi Therapeutics Inc share price today is $10.59, up -0.84%. The stock opened at $10.765 against the previous close of $10.7, with an intraday high of $11.075 and low of $10.38.
Trevi Therapeutics Inc Share Price Chart
Trevi Therapeutics Inc
Trevi Therapeutics Inc Share Price Performance
Trevi Therapeutics Inc Institutional Holdings
Trevi Therapeutics Inc Market Status
Trevi Therapeutics Inc Fundamentals
Market Cap 1362.30 M
PB Ratio 7.2294
PE Ratio 0.0
Enterprise Value 1174.79 M
Total Assets 193.44 M
Volume 2296889
Trevi Therapeutics Inc Company Financials
About Trevi Therapeutics Inc & investment objective
Company Information Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops and commercializes investigational therapy for the treatment of chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and non-IPF interstitial lung disease, and refractory chronic cough. The company develops Haduvio, an oral extended-release formulation of nalbuphine, which is in phase 2b Cough Reduction in IPF with nalbuphine ER clinical trial for treatment of chronic cough in patients with IPF, and phase 2a clinical trial in patients with refractory chronic cough. Trevi Therapeutics, Inc. has a license agreement with Keenova Therapeutics plc to develop and commercialize products incorporating nalbuphine hydrochloride in various formulations. Trevi Therapeutics, Inc. was incorporated in 2011 and is headquartered in New Haven, Connecticut.
Organisation Biotechnology
Employees 34
Industry Biotechnology
CEO Ms. Jennifer L. Good
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Trevi Therapeutics Inc FAQs
What is the share price of Trevi Therapeutics Inc today?
The current share price of Trevi Therapeutics Inc is $10.59.
Can I buy Trevi Therapeutics Inc shares in India?
Yes, Indian investors can buy Trevi Therapeutics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Trevi Therapeutics Inc shares in India?
You can easily invest in Trevi Therapeutics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Trevi Therapeutics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Trevi Therapeutics Inc.
Can I buy fractional shares of Trevi Therapeutics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Trevi Therapeutics Inc?
Trevi Therapeutics Inc has a market cap of $1362.30 M.
In which sector does Trevi Therapeutics Inc belong?
Trevi Therapeutics Inc operates in the Biotechnology sector.
What documents are required to invest in Trevi Therapeutics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Trevi Therapeutics Inc?
The PE ratio of Trevi Therapeutics Inc is N/A and the PB ratio is 7.23.